Six of the 12 specimens displayed G13C, G12F, or G13R KRAS exon 2 mutations, which are not included in the IdyllaTM KRAS Mutation Assay because they are rarely observed (<0.5%) in the large colorectal cancer cohorts published [24–26]. Here, KRAS is linked to colorectal cancer.